2BMonthly Logo
Login
Subscribe
Search

Article Tag: Biotalys

Biotalys and Novozymes Announce Successful Outcome
November 2022
Company News

Biotalys and Novozymes announced the successful outcome of the feasibility study for Evoca, Biotalys’ first proprietary biocontrol product candidate. Through the study, Novozymes obtained proof […]

Read More
Biotalys and Novozymes Partner to Expand Evoca
July 2022
Company News

Biotalys and Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol. The partnership provides that Novozymes will use its […]

Read More
FRAC Grants New Class for Biotalys Active Ingredient in Evoca
May 2022
Company News

Biotalys announced that the Fungicide Resistance Action Committee (FRAC) granted a new class for the active ingredient of its first biofungicide, Evoca. Evoca is a […]

Read More
Biotalys Appoints Dr. Carlo Boutton CSO
April 2022
Personnel

Biotalys has appointed Dr. Carlo Boutton as chief scientific officer (CSO), effective 3 May 2022. In his most recent role as Sanofi’s global head of […]

Read More
Biotalys will Formulate Products at Kwizda Agro facility in Austria
February 2022
Mergers, Acquisitions and Partnerships

Biotalys and Kwizda Agro announced an agreement for Kwizda Agro to act as the formulator of the protein-based biocontrol products developed by Biotalys. Biotalys’ products […]

Read More
Biotalys and Biobest Enter Long Term Partnership
January 2022
Mergers, Acquisitions and Partnerships

Biotalys and Biobest have entered into a long-term partnership whereby Biotalys will offer Biobest a right of first negotiation to reach an exclusive distribution agreement […]

Read More
Olon to Partner with Biotalys
January 2022
Mergers, Acquisitions and Partnerships

Biotalys and Olon, a contract development and manufacturing organization, have entered into a long-term strategic partnership for the manufacturing of Biotalys’ biocontrol products. Under the […]

Read More
Biotalys Project Agrobodies for Crop Protection Receives Funding from Gates Foundation
November 2021
Company News

Biotalys has been awarded a multi-year grant from the Bill & Melinda Gates Foundation to discover novel antifungal biocontrols for deployment to smallholder farmers. The […]

Read More
Biotalys CEO Patrice Sellès
November 2021
Executives Speak

Belgian biotech company Biotalys flexed its muscle earlier this year with a public listing raising €52.8 million. Focused on protein-based biocontrol utilizing nanobodies, the company […]

Read More
Biotalys Announces Appointment of Patrick McDonnell as Chief Business Officer
October 2021
Personnel

Biotalys announced the appointment of Patrick McDonnell as chief business officer, effective 4 October 2021. McDonnell will be based in Biotalys’ offices in Research Triangle […]

Read More
Biotalys to Secure US Regulatory Approval for Evoca
July 2021
Company News

Biotalys expects to secure US Regulatory approval for its  first protein-based biofungicide product, Evoca, and sees a 2024 launch in the European Union. The company […]

Read More
Biotalys to List on Euronext Brussels
July 2021
Company News

Biotalys plans to list on Euronext Brussels, hoping to attract investors with its biological alternatives to chemical pesticides. Biotalys has seven potential products it intends […]

Read More
1 2 3
2BMonthly
A DunhamTrimmer LLC and New Ag International Publication
info@2Bmonthly.com

DunhamTrimmer LLC
11523 Palmbrush Trail, Suite 301
Lakewood Ranch, FL 34202 USA

New Ag International
A brand of Informa Connect Limited

5 Howick Place
London, SW1P 1WG, UK

Copyright ©2022 2BMonthly. All Rights Reserved.
Terms and Conditions